# PICS (NCT06108596)

> Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06108596
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: The First Affiliated Hospital with Nanjing Medical University
- Conditions: Locally Advanced Rectal Adenocarcinoma
- Interventions: Sintilimab with Interleukin-2+CAPOX
- Enrollment: 33
- Primary outcome: pCR

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 4
- X threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=pics-nct06108596